COVID-19 pre-exposure prophylaxis with tixagevimab/cilgavimab in patients with haematological malignancy: A single-centre experience

被引：0
|
作者：
Lee, Kee Tat [1 ]
Low, Woei Chyuan [1 ]
Tan, Sui Keat [1 ]
Chiang, Su Kien [1 ]
Chew, Teng Keat [1 ]
Goh, Ai Sim [1 ]
机构：
[1] Hosp Pulau Pinang, Hematol, Georgetown, Malaysia
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2023年 / 201卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
BSH23-EP51
引用
收藏
页码：167 / 167
页数：1
相关论文
共 50 条
  • [1] COVID-19 pre-exposure prophylaxis with tixagevimab/cilgavimab in patients with haematological malignancy: A single-centre experience
    Lee, Kee Tat
    Low, Woei Chyuan
    Tan, Sui Keat
    Chiang, Su Kien
    Chew, Teng Keat
    Goh, Ai Sim
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 : 167 - 167
  • [2] PRE-EXPOSURE PROPHYLAXIS OF COVID-19 WITH TIXAGEVIMAB AND CILGAVIMAB IN RHEUMATOLOGIC PATIENTS TREATED WITH RITUXIMAB: DATA FROM A SINGLE-CENTRE COHORT
    Manara, M.
    Sette, M.
    Giudice, L.
    Biggioggero, M.
    Del Papa, N.
    Favalli, E. G.
    Gerosa, M.
    Ingegnoli, F.
    Caporali, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 537 - 538
  • [3] Tixagevimab and Cilgavimab (Evusheld) for Pre-Exposure Prophylaxis of COVID-19
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2022, 64 (1641): : 1 - 2
  • [4] Tixagevimab and Cilgavimab (Evusheld) for Pre-Exposure Prophylaxis of COVID-19
    Abramowicz, Mark
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (04): : 384 - 385
  • [5] PRE-EXPOSURE PROPHYLAXIS WITH TIXAGEVIMAB/ CILGAVIMAB: SINGLE CENTRE EXPERIENCE IN A COHORT OF RHEUMATIC PATIENTS
    Cuzzocrea, F.
    Grieco, G. P.
    Bartoletti, A.
    Delvino, P.
    Esposito, G. L.
    Lilleri, D.
    Girardi, D.
    Cusato, M.
    Calvi, M.
    Marena, C.
    Montecucco, C.
    Codullo, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 2036 - 2037
  • [6] Early Experience of Breakthrough COVID-19 Infections in Patients Who Received Pre-exposure Prophylaxis with Tixagevimab/cilgavimab
    Calabrese, Cassandra
    Kirchner, Elizabeth
    Forte, Alexandra Villa
    Hajj-Ali, Rula
    Langford, Carol
    Fernandez, James
    Carlson, Alise
    Moss, Brandon
    Sayles, Vickie
    Pallotta, Andrea
    Kim, Alice
    Calabrese, Leonard
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1549 - 1550
  • [7] Pre-exposure immunization by tixagevimab/cilgavimab in hematological malignancy and covid-19 in the epicovideha registry
    Salmanton-Garcia, J.
    Marchesi, F.
    Buquicchio, C.
    Itri, F.
    Besson, C.
    Rahimli, L.
    Glenthoj, A.
    Cornely, O. A.
    Pagano, L.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 291 - 292
  • [8] Breakthrough COVID-19 is mild in vaccinated patients with hematological malignancy receiving tixagevimab-cilgavimab as pre-exposure prophylaxis
    Hall, V. G.
    Lim, C.
    Saunders, N. R.
    Klimevski, E.
    Nguyen, T. H. O.
    Kedzierski, L.
    Seymour, J. F.
    Wadhwa, V.
    Thursky, K. A.
    Yong, M. K.
    Kedzierska, K.
    Slavin, M. A.
    Teh, B. W.
    LEUKEMIA & LYMPHOMA, 2023,
  • [9] Safety and immunogenicity of cilgavimab-tixagevimab for COVID-19 pre-exposure prophylaxis in immunocompromised patients
    Fernandez-Prada, Maria
    Perez-Martin, Jaime Jesus
    Cienfuegos-Gonzalez, Paula
    MEDICINA CLINICA, 2023, 160 (10): : 458 - 459
  • [10] Pre-Exposure Prophylaxis and Treatment with Tixagevimab/Cilgavimab for COVID-19 among Immunocompromised Pediatric Patients
    Fraczkiewicz, Jowita
    Pawinska-Wasikowska, Katarzyna
    Szymbor, Katarzyna
    Balwierz, Walentyna
    Skoczen, Szymon
    Czyzewski, Krzysztof
    Koltan, Sylwia
    Styczynski, Jan
    Malecka, Anna
    Irga-Jaworska, Ninela
    Trelinska, Joanna
    Mlynarski, Wojciech
    Zajac-Spychala, Olga
    Sobkowiak-Sobierajska, Agnieszka
    Derwich, Katarzyna
    Bal, Wioletta
    Chaber, Radoslaw
    Ksiazek, Agnieszka
    Szczepanski, Tomasz
    Zawitkowska, Joanna
    Drabko, Katarzyna
    Chodala-Grzywacz, Agnieszka
    Karolczyk, Grazyna
    Kobierzycki, Christopher
    Kalwak, Krzysztof
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (07)
12345